177 related articles for article (PubMed ID: 2160612)
1. Role of herpes simplex virus reactivation in chemotherapy-induced oral mucositis.
Redding SW
NCI Monogr; 1990; (9):103-5. PubMed ID: 2160612
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection.
Djuric M; Jankovic L; Jovanovic T; Pavlica D; Brkic S; Knezevic A; Markovic D; Milasin J
J Oral Pathol Med; 2009 Feb; 38(2):167-73. PubMed ID: 18713235
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
4. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
[TBL] [Abstract][Full Text] [Related]
5. The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients.
Woo SB; Sonis ST; Sonis AL
Cancer; 1990 Dec; 66(11):2375-9. PubMed ID: 2173971
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
Demarosi F; Bez C; Carrassi A
Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 for prophylaxis of oral mucositis following BMT.
Labar B; Mrsić M; Pavletić Z; Bogdanić V; Nemet D; Aurer I; Radman I; Filipović-Grcić N; Sertić D; Kalenić S
Bone Marrow Transplant; 1993 May; 11(5):379-82. PubMed ID: 8504271
[TBL] [Abstract][Full Text] [Related]
8. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.
Weisdorf DJ; Bostrom B; Raether D; Mattingly M; Walker P; Pihlstrom B; Ferrieri P; Haake R; Goldman A; Woods W
Bone Marrow Transplant; 1989 Jan; 4(1):89-95. PubMed ID: 2647192
[TBL] [Abstract][Full Text] [Related]
9. HSV excretion after bone marrow transplantation: a 4-year survey.
Morfin F; Bilger K; Boucher A; Thiebaut A; Najioullah F; Bleyzac N; Raus N; Bosshard S; Aymard M; Michallet M; Thouvenot D
J Clin Virol; 2004 Aug; 30(4):341-5. PubMed ID: 15163425
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus and oral mucositis in children with cancer.
Carrega G; Castagnola E; Canessa A; Argenta P; Haupt R; Dini G; Garaventa A
Support Care Cancer; 1994 Jul; 2(4):266-9. PubMed ID: 8087447
[TBL] [Abstract][Full Text] [Related]
11. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation.
McGuire DB; Altomonte V; Peterson DE; Wingard JR; Jones RJ; Grochow LB
Oncol Nurs Forum; 1993; 20(10):1493-502. PubMed ID: 8278277
[TBL] [Abstract][Full Text] [Related]
12. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
13. Measurement of secondary mucositis to oncohematologic treatment by means of different scale. Review.
López-Castaño F; Oñate-Sánchez RE; Roldán-Chicano R; Cabrerizo-Merino MC
Med Oral Patol Oral Cir Bucal; 2005; 10(5):412-21. PubMed ID: 16264377
[TBL] [Abstract][Full Text] [Related]
14. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.
Elting LS; Cooksley C; Chambers M; Cantor SB; Manzullo E; Rubenstein EB
Cancer; 2003 Oct; 98(7):1531-9. PubMed ID: 14508842
[TBL] [Abstract][Full Text] [Related]
15. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation.
Iino T; Gondo H; Ohno Y; Minagawa H; Iwasaki H; Maruyama T; Nakashima H; Niho Y
Bone Marrow Transplant; 1996 Dec; 18(6):1185-8. PubMed ID: 8971394
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study.
Ramphal R; Grant RM; Dzolganovski B; Constantin J; Tellier R; Allen U; Weitzman S; Matlow A; Petric M; Sung L
Pediatr Infect Dis J; 2007 Aug; 26(8):700-4. PubMed ID: 17848881
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy.
Epstein JB; Gorsky M; Hancock P; Peters N; Sherlock CH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):712-6. PubMed ID: 12464896
[TBL] [Abstract][Full Text] [Related]
18. Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants.
Redding SW; Montgomery MT
Oral Surg Oral Med Oral Pathol; 1989 Jun; 67(6):680-3. PubMed ID: 2544843
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy: the effect of oral cryotherapy on the development of mucositis.
Karagözoğlu S; Filiz Ulusoy M
J Clin Nurs; 2005 Jul; 14(6):754-65. PubMed ID: 15946284
[TBL] [Abstract][Full Text] [Related]
20. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
